A family in Georgia is mourning after a 5-year-old boy -- described as someone who had 'nothing but pure love' -- died just days after being diagnosed with Covid-19.
A family in Georgia is mourning after a 5-year-old boy -- described as someone who had"nothing but pure love" -- died just days after being diagnosed with Covid-19.
Wyatt Gibson suffered a stroke and died on July 16 in a Chattanooga, Tennessee, hospital where he'd been intubated because he was having trouble breathing and his oxygen levels were low, his godmother Amanda Summey told CNN.Child cases of Covid-19 are rising as schools gear up to reopen.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
COVID-19 Cases In U.S. Triple Over 2 Weeks Amid MisinformationCOVID-19 cases have tripled in the U.S. over two weeks amid an onslaught of vaccine misinformation.
Consulte Mais informação »
Cape Cod COVID-19 cluster grows to more than 130 infected, prompting renewed mitigation effortsOfficials in Provincetown, Massachusetts, issued a number of renewed mitigation measures on Monday after at least 132 individuals tested positive for COVID-19 in the weeks after the holiday weekend.
Consulte Mais informação »
Why breakthrough COVID-19 infections don't mean the vaccine isn't workingBreakthrough COVID-19 cases aren't proof the vaccines aren't working, experts say, but are normal and expected.
Consulte Mais informação »
South Korea logs record rise in daily Covid-19 cases - latest updatesSouth Korea logs another record rise in daily Covid-19 cases. Here are other updates: 🇵🇪 Peru arrests hospital workers over bed scam 🇦🇺 Victoria state's cases rise amid lockdowns in Australia 🇺🇸 President Biden urges vaccinations at town hall For more:
Consulte Mais informação »
J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine salesJohnson & Johnson (JNJ.N) raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine this year, as it strives to quell production and safety problems and catch up with rivals Pfizer and Moderna.
Consulte Mais informação »